I now have solid data from multiple authoritative sources. Here is a full clinical answer:
Dual Antiplatelet Therapy (DAPT) in CABG Patients
Why DAPT Is Used
After CABG - especially off-pump CABG - DAPT (aspirin + a P2Y12 inhibitor) is used to:
- Maintain saphenous vein graft (SVG) patency
- Reduce recurrent ischemic/coronary events
- Provide continued protection after an underlying ACS that prompted surgery
DAPT is a Class I recommendation specifically after off-pump CABG. After on-pump CABG, aspirin alone is the standard, unless the patient had a recent ACS or other indication for continued P2Y12 therapy.
- Goldman-Cecil Medicine, antiplatelet section
DAPT Agents Used Post-CABG
| Drug | Mechanism | Dose | Hold Before CABG |
|---|
| Aspirin | COX inhibitor (irreversible) | 81-325 mg | Do NOT stop |
| Clopidogrel | ADP (P2Y12) blocker - irreversible | 75 mg/day | 5 days before elective CABG |
| Ticagrelor | P2Y12 blocker - reversible | 90 mg BD | 3-5 days before elective CABG |
| Prasugrel | P2Y12 blocker - irreversible | 10 mg/day | 7 days before elective CABG |
Current Surgical Therapy, 14th ed.
Pre-operative Considerations (If CABG is Planned)
- Aspirin: Continue. No need to stop before CABG. Aspirin within 6 hours post-CABG improves SVG patency. Current Surgical Therapy, 14th ed.
- Clopidogrel: Should be withheld ~5 days before elective CABG. Discontinuing it less than 24 hours before surgery increases major bleeding (reoperation, tamponade, transfusion) by ~2%.
- Ticagrelor: ACC/AHA recommend holding for at least 24 hours before urgent on-pump CABG; 3-5 days before elective surgery.
- If urgent CABG is needed and the patient is on DAPT: proceed with surgery but accept the higher bleeding risk, which must be weighed against ischemic risk. Rosen's Emergency Medicine
Perioperative Bleeding Risk
CABG patients on DAPT have a greater incidence of perioperative bleeding. However:
"This increased hemorrhagic rate must be weighed against the benefit in reducing ischemic risk in these patients." - Rosen's Emergency Medicine
Strategies to reduce bleeding risk:
- Use aspirin 81 mg (not higher dose) when combining with a P2Y12 agent
- Platelet transfusion is an option if major bleeding occurs on irreversible agents (clopidogrel, prasugrel)
- Ticagrelor's reversible binding means platelet function recovers faster after discontinuation
Post-CABG DAPT Duration
The duration depends on the indication:
| Indication | Recommended Duration |
|---|
| ACS (low-intermediate bleeding risk) | Up to 12 months |
| ACS (high/very high bleeding risk) | 1-3 months |
| High ischemic risk (DM, recurrent MI, CKD, LM disease, stent thrombosis history) | Consider extended >12 months |
| Off-pump CABG (non-ACS) | DAPT is recommended (duration varies by guideline) |
| On-pump CABG, stable CAD | Aspirin alone is generally sufficient |
Goldman-Cecil Medicine; Braunwald's Heart Disease
DAPT Nonadherence
DAPT nonadherence is actually listed as a clinical scenario where CABG is preferred over PCI - because a patient who cannot reliably take DAPT is at risk of stent thrombosis with PCI, making CABG the safer revascularization choice.
- Sabiston Textbook of Surgery
Key Recent Evidence
- A 2024 meta-analysis in Heart found DAPT (ticagrelor + aspirin) improved SVG patency and reduced MACE vs. aspirin alone post-CABG, especially in ACS patients (PMID 37648436).
- A 2024 network meta-analysis in Perfusion confirmed DAPT safety data post-CABG, though bleeding risk is higher than aspirin monotherapy (PMID 36803180).
- A 2026 systematic review in J Thromb Thrombolysis on ticagrelor-based DAPT vs aspirin alone post-CABG: ticagrelor arm showed benefits in SVG patency without a significant increase in major bleeding (PMID 41718996).
Summary: In a CABG patient on DAPT - continue aspirin always, hold the P2Y12 agent appropriately before elective surgery (5 days for clopidogrel, 3-5 days for ticagrelor, 7 days for prasugrel), and resume DAPT post-op based on the indication (mandatory after off-pump CABG and post-ACS). Duration is typically 12 months for ACS, shorter for high bleeding risk, and possibly longer for high ischemic risk patients.